Chuan Yang
State Key Laboratory Of Oncology In South China
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Clinical applications of circulating tumor cells in metastasis and therapy.
Journal: Journal of hematology & oncology
Published: May 13, 2025
Cardiotoxicity of small-molecule kinase inhibitors in cancer therapy.
Journal: Experimental hematology & oncology
Published: February 03, 2025
Resistance to antibody-drug conjugates: A review.
Journal: Acta pharmaceutica Sinica. B
Published: November 20, 2024
The culture and application of circulating tumor cell-derived organoids.
Journal: Trends in cell biology
Published: July 19, 2024
BI-2865, a pan-KRAS inhibitor, reverses the P-glycoprotein induced multidrug resistance in vitro and in vivo.
Journal: Cell communication and signaling : CCS
Published: March 15, 2024
Small-molecule agents for cancer immunotherapy.
Journal: Acta pharmaceutica Sinica. B
Published: September 25, 2023
The strategies to cure cancer patients by eradicating cancer stem-like cells.
Journal: Molecular cancer
Published: July 31, 2023
Circulating tumor cells shielded with extracellular vesicle-derived CD45 evade T cell attack to enable metastasis.
Journal: Signal transduction and targeted therapy
Published: July 10, 2023
A20 promotes colorectal cancer immune evasion by upregulating STC1 expression to block "eat-me" signal.
Journal: Signal transduction and targeted therapy
Published: February 10, 2023
Predictive Nomogram for Hyperprogressive Disease During Anti-PD-1/PD-L1 Treatment in Patients with Advanced Non-Small Cell Lung Cancer.
Journal: ImmunoTargets and therapy
Published: May 18, 2022
Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells in vitro, in vivo, and ex vivo.
Journal: Molecular therapy oncolytics
Published: June 09, 2021
Last Updated: 09/26/2026